Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Jublia, Clenafin
Efinaconazole is a topical antifungal medication used to treat onychomycosis, a fungal infection of the toenails or fingernails. It belongs to the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes. This disruption leads to fungal cell death and helps clear the infection.
For the topical treatment of onychomycosis of the toenail or fingernail.
Outcome:
N/A
Mechanism:
N/A
Outcome:
No clinically significant interaction expected.
Mechanism:
Efinaconazole is applied topically and has minimal systemic absorption.
Outcome:
No clinically significant interaction expected.
Mechanism:
Efinaconazole is applied topically and has minimal systemic absorption.
Most likely new formulation: Topical solution with enhanced penetration (Year: 2025, 70% confidence)
Based on current usage patterns and clinical trial data, there is a high likelihood (>80%) of efinaconazole maintaining its current regulatory status in the near future.
Antifungal
Triazole